Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Presciutti

Orthopaedic Surgery of the Spine Decatur, GA Medical Doctor

NPI 1821225293 CMS profile 1353100

1670 Clairmont Rd, Decatur, GA 30033

Open in the dashboard

General payments

$48,186

38 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Presciutti of Decatur, GA is reported in the CMS Open Payments database as having received $48,186 across 38 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,991 4
2024 General $448 3
2023 General $1,267 10
2022 General $1,934 11
2021 General $241 5
2020 General $17 1
2019 General $289 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Presciutti
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Steven Presciutti were reported at $43,991. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Steven Presciutti Orthopaedic Surgery of the Spine median Middle half National median
2019 $289 $2,106 $337–$18,608 $163
2020 $17 $1,213 $156–$15,082 $114
2021 $241 $1,834 $271–$15,617 $132
2022 $1,934 $2,015 $320–$17,036 $149
2023 $1,267 $1,925 $336–$14,599 $160
2024 $448 $2,110 $341–$12,483 $164
2025 $43,991 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. 4WEB, Inc. $45,658 15 payments
  2. Biedermann Motech, Inc. $1,988 10 payments
  3. Alphatec Spine, Inc $174 2 payments
  4. Misonix Inc $97 1 payment
  5. Medtronic USA, Inc. $55 2 payments
  6. Medtronic, Inc. $44 1 payment
  7. DePuy Synthes Sales Inc. $41 2 payments
  8. Stryker Corporation $40 1 payment
  9. Baxter Healthcare $39 1 payment
  10. Arteriocyte Medical Systems, Inc. $26 1 payment
  11. Other $25 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $31,768 2 payments
  2. Travel and Lodging $14,609 8 payments
  3. Food and Beverage $1,771 27 payments
  4. Debt forgiveness $39 1 payment
Products named General payments · program years 2019–2025
  1. SPINE TRUSS SYSTEM $45,658 15 payments
  2. MOSS VRS Spinal System $1,988 10 payments
  3. MOSS100 Pedicle Screw System $351 6 payments
  4. Telix K Interbody System $351 6 payments
  5. BoneScalpel $97 1 payment
  6. ENDOSKELETON TL NANOLOCK SURFACE TECHNOLOGY $44 1 payment
  7. SPINEMASK $40 1 payment
  8. CATALYST $38 1 payment
  9. Magellan $26 1 payment
  10. InFlux $26 1 payment
  11. Other $119 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

303

Median for Orthopedic Surgery: 203

Drug cost

$2,152

Median for Orthopedic Surgery: $1,433

Branded share of claims

9.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 106 $905
Tramadol Hcl Generic 71 $367
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $284
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $192
Pregabalin Generic 27 $162
Cyclobenzaprine Hcl Generic 19 $83
Diclofenac Sodium Generic 13 $73
Prednisone Generic 21 $47
Meloxicam Generic 17 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$70,131

Medicare's payments for the services billed

Medicare patients

165

Average age 73

Services billed

506

95 women, 70 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 30%
Ischemic heart disease 27%
Depression 27%
Chronic kidney disease 25%
Osteoporosis 21%
COPD 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

38 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record